These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30681998)

  • 1. Genetic Service Delivery Models: Exploring Approaches to Care for Families With Hereditary Cancer Risk.
    Pierle JM; Mahon SM
    Clin J Oncol Nurs; 2019 Feb; 23(1):60-67. PubMed ID: 30681998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
    Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
    BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.
    Powers J; Stopfer JE
    J Obstet Gynecol Neonatal Nurs; 2014; 43(3):361-73. PubMed ID: 24689498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
    Lewis KM
    Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of survivorship in cancer genetic care.
    Jacobs LA; Giarelli E
    Semin Oncol Nurs; 2004 Aug; 20(3):196-202. PubMed ID: 15491029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Cancer Risk Assessment for Breast Cancer in Latin America.
    Chavarri-Guerra Y; Blazer KR; Weitzel JN
    Rev Invest Clin; 2017; 69(2):94-102. PubMed ID: 28453507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
.
    Fournier DM; Bazzell AF; Dains JE
    Oncol Nurs Forum; 2018 Jan; 45(1):96-105. PubMed ID: 29251290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical aspects of delivering hereditary cancer risk counseling.
    DeMarco TA; Smith KL; Nusbaum RH; Peshkin BN; Schwartz MD; Isaacs C
    Semin Oncol; 2007 Oct; 34(5):369-78. PubMed ID: 17920890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common hereditary cancer syndromes.
    Greco KE; Mahon S
    Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial aspects of genetic counseling and testing.
    Vadaparampil ST; Wey JP; Kinney AY
    Semin Oncol Nurs; 2004 Aug; 20(3):186-95. PubMed ID: 15491028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
    King E; Mahon SM
    Clin J Oncol Nurs; 2017 Oct; 21(5):589-598. PubMed ID: 28945723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer.
    Green MJ; Fost N
    J Cancer Educ; 1997; 12(4):204-8. PubMed ID: 9440011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current state of cancer genetic counseling access and availability.
    Knapke S; Haidle JL; Nagy R; Pirzadeh-Miller S
    Genet Med; 2016 Apr; 18(4):410-2. PubMed ID: 26248009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I remember how I felt, but I don't remember the gene": Families' experiences of cancer-related genetic testing in childhood.
    McGill BC; Wakefield CE; Vetsch J; Lim Q; Warby M; Metcalfe A; Byrne JA; Cohn RJ; Tucker KM
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27762. PubMed ID: 31006986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dealing with the uncertainty of developing a cancer.
    Murphy AE
    Eur J Cancer Care (Engl); 1999 Dec; 8(4):233-7. PubMed ID: 10889621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
    Buchanan AH; Datta SK; Skinner CS; Hollowell GP; Beresford HF; Freeland T; Rogers B; Boling J; Marcom PK; Adams MB
    J Genet Couns; 2015 Dec; 24(6):961-70. PubMed ID: 25833335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.